1-14 of 14
Zaoli Jiang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 526: Alternative format bispecific antibodies targeting multiple oncogenic FGFR3 mutations in bladder cancer through different mechanisms

Yan Yang, Arif Wibowo, Suhasini Avvaru, Zaoli Jiang, Antonio Luz, Ashique Rafique, Prasad Sarangapani, Ryan McKay, Michael Amatulli, Meghana Vootlakrishna, Rachel Edwards, Terra Potocky, Aynur Hermann, Christopher Daly, Gavin Thurston, John Chia-Yang Lin, Yang Shen
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 526.
DOI: https://doi.org/10.1158/1538-7445.AM2020-526
Published: 15 August 2020
View article
Journal Articles

Abstract 2252: YIV-906 (PHY906) enhanced the anti-tumor activity of immune checkpoint blockade therapy (Anti-PD1) against liver cancer by changing the tumor micro-environment associated with M1 macrophages infiltration

Wing Lam, Xiaochen Yang, Zaoli Jiang, Xue han, Fulan Guan, Rong Hu, Chang-Hua Xu, Wei Cai, William Cheng, Shwu-Huey Liu, Yuping Cai, Nicholas Rattray, Caroline Johnson, Lieping Chen, Yung-chi Cheng
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 2252.
DOI: https://doi.org/10.1158/1538-7445.AM2019-2252
Published: 01 July 2019
View article
Journal Articles

Abstract 2724: YIV906 (PHY906) enhanced the antitumor activity of immune checkpoint blockade therapy: Anti-PD1 against liver cancer

Wing Lam, XiaoChen Yang, Zaoli Jiang, Xue Han, Fulan Guan, William Cheng, Shwu-Huey Liu, Lieping Chen, Yung-Chi Cheng
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 2724.
DOI: https://doi.org/10.1158/1538-7445.AM2018-2724
Published: 01 July 2018
View article
Journal Articles

Abstract 5584: PHY906(YIV-906), an adjuvant based on a 1800-year-old Chinese medicine, enhanced the anti-tumor activity of Immune checkpoint blockade therapy: anti-PDL1, anti-PD1, anti-PD1/CTLA4 against melanoma

Wing Lam, Zaoli jiang, Xue han, Shwu-Huey Liu, Lieping Chen, YungChi Cheng
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 5584.
DOI: https://doi.org/10.1158/1538-7445.AM2017-5584
Published: 01 July 2017
View article
Journal Articles

Abstract 3138: Mechanism based quality control (MBQC) for the four-herb Chinese medicine formulation, PHY906(YIV-906) and other herbal products

Wing Lam, Yongshen Ren, Fulan Guan, Zaoli jiang, William Cheng, Shwu-Huey Liu, YungChi Cheng
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 3138.
DOI: https://doi.org/10.1158/1538-7445.AM2017-3138
Published: 01 July 2017
View article
Journal Articles

Abstract #4584: Exploration of the mechanisms of PHY906 in reducing the intestinal toxicity caused by irinotecan

Wing Lam, Scott Bussom, Fulan Guan, Zaoli Jiang, Shwu-Huey Liu, YungChi Cheng
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 4584.
Published: 01 May 2009
View article
Journal Articles

A novel herb-drug interaction: Irinotecan can significantly change the pharmacokinetics and pharmacodynamics of PHY906, a Chinese medicine formulation for cancer therapy

Min Ye, Zaoli Jiang, Wing Lam, Ginger Dutschman, Scott Bussom, Pei-chun Chen, Shwu-Huey Liu, Yung-Chi Cheng
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 635.
Published: 01 May 2008
View article
Journal Articles

PHY906 in hepatocellular carcinoma

Shwu-Huey Liu, Zaoli Jiang, Angeline Foo, Wing Lam, Min Ye, Yashang Lee, Duncan Liang, Susan Grill, Yun Yen, Michal Rose, Samuel So, Wasif Saif, Edward Chu, Robert Tilton, Yung-Chi Cheng
Journal: Cancer Research
Cancer Res (2007) 67 (9_Supplement): 1841.
Published: 01 May 2007
View article
Journal Articles

PHY906 as a broad-spectrum enhancer in cancer therapy: Clinical and preclinical results in hepatocellular carcinoma

Shwu-Huey Liu, Angeline Foo, Zaoli Jiang, Rajendra Marathe, Jing Guan, Tah-Mun Su, Robert Tilton, Yun Yen, Michal Rose, Samuel So, Edward Chu, Yung-Chi Cheng
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 506–507.
Published: 15 April 2006
View article
Journal Articles

Dipropyloxy baicalein, a biochemical modulator in facilitating the oral uptake of drugs

Shwu-Huey Liu, Yashang Lee, Zaoli Jiang, Yung-Chi Cheng
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 506.
Published: 15 April 2006
View article
Journal Articles

Increasing the anti-P-glycoprotein activity of baicalein by alkylated modification.

Yashang Lee, Hosup Yeo, Shwu-Huey Liu, Zaoli Jiang, Yung-Chi Cheng
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 494.
Published: 01 April 2004
View article
Journal Articles

Developing PHY906 as a broad- spectrum modulator of chemotherapeutic agents in cancer therapy

Shwu-Huey Liu, Zaoli Jiang, Tah-Mun Su, Wen-Yi Gao, Chung-Hang Leung, Yashang Lee, Yung-Chi Cheng
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 128.
Published: 01 April 2004
View article
Journal Articles

Exploration of a Chinese herb, isodon rubescens, for cancer treatment with focus on modulation of nuclear factor-kappa B activity.

Chung H. Leung, Her S. Shiah, Shwu H. Liu, Zaoli Jiang, Wenli Gao, Wing Lam, Susan P. Grill, Quan B. Han, Han D. Sun, Yung C. Cheng
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 704.
Published: 01 April 2004
View article
Journal Articles

Characterization of Human UMP/CMP Kinase and Its Phosphorylation of d- and l-Form Deoxycytidine Analogue Monophosphates1

Jieh-Yuan Liou, Ginger E. Dutschman, Wing Lam, Zaoli Jiang, Yung-Chi Cheng
Journal: Cancer Research
Cancer Res (2002) 62 (6): 1624–1631.
Published: 15 March 2002
View article
PDF